The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

orbustherapeutics.com

Total Raised

$71M

Investors Count

6

Deal Terms

2

Orbus Therapeutics Funding, Orbus Therapeutics Valuation & Orbus Therapeutics Revenue

4 Fundings

Orbus Therapeutics's latest funding round was a Series A - IV for $10M on October 22, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

10/22/2020

Series A - IV

$10M

0

FY undefined

1

8/11/2020

Series A - III

$99M

0

FY undefined

10

8/15/2017

Series A - II

$99M

0

FY undefined

10

8/19/2015

Series A

$99M

0

FY undefined

10

Date

10/22/2020

8/11/2020

8/15/2017

8/19/2015

Round

Series A - IV

Series A - III

Series A - II

Series A

Amount

$10M

$99M

$99M

$99M

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

10

Orbus Therapeutics Deal Terms

2 Deal Terms

Orbus Therapeutics's deal structure is available for 2 funding rounds, including their Series A - II from August 15, 2017.

Round

Series A - II

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

$99M

$99M

Dividend Rate

Liquidation Preferences

$99M

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

$99M

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A - II

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Orbus Therapeutics Investors

6 Investors

Orbus Therapeutics has 6 investors. Longitude Capital invested in Orbus Therapeutics's Series A - IV funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

8/19/2015

10/22/2020

4
Series A, Series A - II (2017), Series A - III (2020), Series A - IV (2020)

Venture Capital

California

00/00/0000

00/00/0000

H.I.G. BioHealth Partners

Subscribe to see more

Venture Capital

Florida

00/00/0000

00/00/0000

Adams Street Partners

Subscribe to see more

Private Equity

Illinois

00/00/0000

00/00/0000

Abingworth

Subscribe to see more

Subscribe to see more

Venture Capital

United Kingdom

00/00/0000

00/00/0000

Pappas Ventures

Subscribe to see more

Venture Capital

North Carolina

First funding

8/19/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

10/22/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

H.I.G. BioHealth Partners

Adams Street Partners

Abingworth

Pappas Ventures

Rounds

4
Series A, Series A - II (2017), Series A - III (2020), Series A - IV (2020)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Venture Capital

Venture Capital

Private Equity

Venture Capital

Venture Capital

Location

California

Florida

Illinois

United Kingdom

North Carolina

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.